Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Insulin Maker Lilly Seeks US FDA Assurances On ‘Authorized Biologics’

Feb 21 2019

• By Sue Sutter

insulin hormone vials-single use syringe_1200x675

Related Content

US Biosimilars: FDA Seeks To Build On Record Number Of Approvals, But Shutdown May Blunt Progress

Jan 23 2019

US FDA's Gottlieb Shuts The Door On Exclusivity For 'Transition' Biologics

Dec 11 2018

When Drugs Become Biologics: US FDA Guidances Explain 'Transition Provisions'

Dec 11 2018

Related Companies

Eli Lilly and Company

Boehringer Ingelheim GmbH

Sanofi

Additional Topics

United States Biologics Biosimilars Regulation Pricing Debate BioPharmaceutical Metabolic Disorders

More from Biosimilars

More from Biosimilars & Generics

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window